Motif-programmed artificial protein induces apoptosis in several cancer cells by disrupting mitochondria
スポンサーリンク
概要
- 論文の詳細を見る
- 2008-02-10
著者
-
YAMORI Takao
Division of Molecular Pharmacology, Cancer Chemotherapy Center, Japanese Foundation for Cancer Resea
-
Yamori Takao
Division Of Experimental Chemotherapy Cancer Chemotherapy Center Japanese Foundation For Cancer
-
SHIBA Kiyotaka
Department of Protein Engineering Cancer Institute, Japanese Foundation for Cancer Research
-
Shiba Kiyotaka
Department Of Protein Engineering Cancer Institute Japanese Foundation For Cancer Research
-
SAITO Hirohide
Department of Protein Engineering, Cancer Institute, Japanese Foundation for Cancer Research
-
MINAMISAWA Tamiko
Department of Protein Engineering, Cancer Institute, Japanese Foundation for Cancer Research
-
Yamori Takao
Division Of Molecular Pharmacology Cancer Chemotherapy Center Japanese Foundation For Cancer Researc
-
Saito Hirohide
Department Of Gene Mechanisms Graduate School Of Biostudies Kyoto University
-
Saito Hirohide
Department Of Protein Engineering Cancer Institute Japanese Foundation For Cancer Research
-
Minamisawa Tamiko
Department Of Protein Engineering Cancer Institute Japanese Foundation For Cancer Research
-
Shiba Kiyotaka
Department of Protein Engineering, Cancer Institute, Japanese Foundation for Cancer Research
関連論文
- Discovery of Phosphatidylinositol 3-Kinase Inhibitory Compounds from the Screening Committee of Anticancer Drugs (SCADS) Library
- YM-216391, a Novel Cytotoxic Cyclic Peptide from Streptomyces nobilis : I. Fermentation, Isolation and Biological Activities
- Pladienolides, New Substances from Culture of Streptomyces platensis Mer-11107 : III. In Vitro and In Vivo Antitumor Activities
- Isolation of a Novel Gene Showing Reduced Expression in Metastatic Colorectal Carcinoma Cell Lines and Carcinomas
- Absolute Quantification of Four Isoforms of the Class I Phosphoinositide-3-kinase Catalytic Subunit by Real-Time RT-PCR(Communications to the Editor)
- Identification of Candidate Genes Determining Chemosensitivity to Anti-cancer Drugs of Gastric Cancer Cell Lines
- Identification of candidate predictive markers of anticancer drug sensitivity using a panel of human cancer cell lines
- Characterization of Folding Pathways of the Type-1 and Type-2 Periplasmic Binding Proteins MgIB and ArgT
- Identification of JTP-70902, a p15^-inductive compound, as a novel MEK1/2 inhibitor
- ANTITUMOR EFFICACIES OF ACLACINOMYCIN A BY ORAL ADMINISTRATION
- Adsorption Properties of a Gold-Binding Peptide Assessed by its Attachment to a Recombinant Apoferritin Molecule
- Establishment of a Hepatocyte Cell Line Producing Growth-promoting Factors for Liver-colonizing Tumor Cells
- Anticancer and Some Biological Activities of Thiazinotrienomycin B
- Development and Characterization of a Model of Liver Metastasis Using Human Colon Cancer HCT-116 Cells(Highlighted paper selected by Editor-in-chief,Miscellaneous)
- Sesquiterpenoids and Flavonoids from the Aerial Parts of Tithonia diversifolia and Their Cytotoxic Activity
- 3P-233 RNA-タンパク質相互作用の共変化の,kink-turn motifにおける相互情報量計算による同定(生命情報科学-分子進化,第47回日本生物物理学会年会)
- Guide Oligonucleotide-Dependent DNA Linkage That Facilitates Controllable Polymerization of Microgene Blocks
- β-Hydroxyisovalerylshikonin Is a Novel and Potent Inhibitor of Protein Tyrosine Kinases
- Synthesis of Artificial Proteins That Have a Cell-Attaching Motif and Titanium-Binding Motif
- Construction and Characterization of Chimeric Proteins Composed of Type-1 and Type-2 Periplasmic Binding Proteins MglB and ArgT
- Biological Functionalization of Titanium Surfaces by Fusion Proteins between BMP-2 and Artificial Proteins Composed of Titanium-Binding Peptide Motifs
- Motif-programmed artificial protein induces apoptosis in several cancer cells by disrupting mitochondria
- Anti-tumor Efficacy of Paclitaxel against Human Lung Cancer Xenografts
- SYNTHESIS OF FUNCTIONAL GENES BY MIXING MICROGENES(From Molecules to Life-Like Systems & RNA World, International Symposium on Origins of Life and Astrobiology)
- Phosphatidylinositol 3-kinase inhibitors : promising drug candidates for cancer therapy
- Effect of ZSTK474, a Novel Phosphatidylinositol 3-Kinase Inhibitor, on DNA-Dependent Protein Kinase(Pharmacology)
- Effectiveness of combined treatment using X-rays and a phosphoinositide 3-kinase inhibitor, ZSTK474, on proliferation of HeLa cells in vitro and in vivo
- ZSTK474 is an ATP-competitive inhibitor of class I phosphatidylinositol 3 kinase isoforms
- Potentiation of Bleomycin in Jurkat Cells by Fungal Pycnidione
- Development of an Immunohistochemical Protein Quantification System in Conjunction with Tissue Microarray Technology for Identifying Predictive Biomarkers for Phosphatidylinositol 3-Kinase Inhibitors
- Search for Novel Anti-tumor Agents from Ridaifens Using JFCR39, a Panel of Human Cancer Cell Lines
- Characterization of Folding Pathways of the Type-1 and Type-2 Periplasmic Binding Proteins MglB and ArgT